Literature DB >> 11831415

Alzheimer's disease and other dementias: a review.

Shannon Rogan1, Carol F Lippa.   

Abstract

Dementia and its associated diseases are important causes of disability and morbidity in developed countries, especially in the aged population. As the babyboomers arrive at retirement and individuals over 100 are one of the fastest growing segments of our nation's population, we may realize the substantial cost these diseases bring to society. Dementia is characterized by a significant loss of cognitive function and should be clinically distinguished from an acute delirium or decreased arousal. Its manifestations cause anguish to millions of caregivers and family members, who are pressed to cope with their loved one's unfortunate decline in multiple cognitive domains, functioning, and behavior. Early detection and management may prevent overuse of costly medical resources and allow patients and family members time to prepare for future medical, financial, and emotional challenges. Diagnostic clues to the etiology of the patient's dementia can be found in a medical workup in which the neurologic history and examination (including mental status examination) are essential and neuroimaging is indicated. Herein, the concept of central nervous system (CNS) degenerative diseases as disorders of specific proteins is introduced. This review is intended to summarize clinical, biological, and genetic features of the common subtypes of dementia, and bring light to potential benefits of early and accurate diagnoses to optimize treatment. Details of the various diseases remain only partially uncovered, raising extensive prospects for future research and therapy for patients with dementia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11831415     DOI: 10.1177/153331750201700106

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  13 in total

1.  Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling.

Authors:  Walter J Lukiw
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 2.  Genetics of Alzheimer disease.

Authors:  Lynn M Bekris; Chang-En Yu; Thomas D Bird; Debby W Tsuang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-12       Impact factor: 2.680

3.  UPDATE ON DEMENTIA WITH LEWY BODIES.

Authors:  Stella Karantzoulis; James E Galvin
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2013-09-01

Review 4.  Inflammatory, apoptotic, and survival gene signaling in Alzheimer's disease. A review on the bioactivity of neuroprotectin D1 and apoptosis.

Authors:  Walter J Lukiw; Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2010-04-23       Impact factor: 5.590

5.  Cortical gyrification and sulcal spans in early stage Alzheimer's disease.

Authors:  Tao Liu; Darren M Lipnicki; Wanlin Zhu; Dacheng Tao; Chengqi Zhang; Yue Cui; Jesse S Jin; Perminder S Sachdev; Wei Wen
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

6.  Lewy Body Dementia: The Under-Recognized but Common FOE.

Authors:  James E Galvin; Meera Balasubramaniam
Journal:  Cerebrum       Date:  2013-10-01

7.  Identification of Early-Stage Alzheimer's Disease Using Sulcal Morphology and Other Common Neuroimaging Indices.

Authors:  Kunpeng Cai; Hong Xu; Hao Guan; Wanlin Zhu; Jiyang Jiang; Yue Cui; Jicong Zhang; Tao Liu; Wei Wen
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

Review 8.  Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.

Authors:  Nagaendran Kandiah; Ming-Chyi Pai; Vorapun Senanarong; Irene Looi; Encarnita Ampil; Kyung Won Park; Ananda Krishna Karanam; Stephen Christopher
Journal:  Clin Interv Aging       Date:  2017-04-18       Impact factor: 4.458

Review 9.  Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders.

Authors:  Seyed Zachariah Moradi; Saeideh Momtaz; Zahra Bayrami; Mohammad Hosein Farzaei; Mohammad Abdollahi
Journal:  Front Bioeng Biotechnol       Date:  2020-04-07

Review 10.  Genetic aspects of Alzheimer disease.

Authors:  Thomas D Bird
Journal:  Genet Med       Date:  2008-04       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.